Skip to main content
OpenTrials
Completed

NCT Number: NCT04347044

The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success

The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined.

Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure.

Changes in the parameters of initial and rehabilitation follow-up will be examined.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18-75
  • Patients with a diagnosis of emphysema and bronchoscopic procedures

Exclusion criteria

  • Patients who develop complications related to the procedure after bronchoscopic procedure.

Treatment and study plan

Pulmonary Rehabilitation

Other

Exercise training+ Optimal medication and clinical follow-up

standart care

Other

Optimal medication and clinical follow-up

Primary outcomes

  1. Six minute walking test

    Time frame: 20 minutes

    The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded

  2. Pulmonary Function Tests

    Time frame: 15 minutes

    PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines

Secondary outcomes

  1. Carbonmonoxide diffusion test

    Time frame: 15 minutes

    It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique

Sponsors and collaborators

Lead sponsor

Istanbul Medipol University Hospital

Other

Registry information

Important dates

Study start
2013
Primary completion
2020
Study completion
2020
First posted
Apr 15, 2020
Registry last updated
Aug 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.